Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
348 |
|
Actual shortage: | 11 (3%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 34 (10%) | |
Resolved: | 303 (87%) | |
Discontinuation Reports |
13 |
|
To be discontinued: | 1 (8%) | |
Discontinued: | 12 (92%) | |
Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
LODALIS | 625MG | TABLET | Resolved | 2020-04-01 | 2020-04-09 | 110373 |
LODALIS | 625MG | TABLET | Resolved | 2020-08-13 | 2020-09-10 | 122119 |
LODALIS | 625MG | TABLET | Avoided shortage | 2020-10-21 | 2020-10-21 | 126828 |
LODALIS | 625MG | TABLET | Resolved | 2023-01-11 | 2023-03-04 | 180700 |
LODALIS | 625MG | TABLET | Resolved | 2024-01-25 | 2024-03-26 | 217261 |
LODALIS | 625MG | TABLET | Actual shortage | 2024-05-01 | 2024-05-15 | 226788 |
EDARBI | 40MG | TABLET | Resolved | 2019-06-21 | 2019-06-27 | 87192 |
EDARBI | 40MG | TABLET | Resolved | 2019-09-10 | 2019-11-19 | 93519 |
EDARBI | 40MG | TABLET | Resolved | 2020-01-10 | 2020-02-28 | 103031 |
EDARBI | 40MG | TABLET | Resolved | 2020-04-01 | 2020-05-13 | 110370 |
EDARBI | 80MG | TABLET | Resolved | 2019-09-10 | 2019-11-19 | 93523 |
EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2018-08-24 | 2019-01-23 | 58987 |
EDARBYCLOR | 12.5MG 40MG | TABLET | Avoided shortage | 2019-05-08 | 2019-05-23 | 83479 |
EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-07-05 | 2019-08-14 | 88781 |
EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-11-13 | 2020-01-23 | 98634 |
EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2020-04-01 | 2020-04-24 | 110367 |
EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2018-08-24 | 2018-11-09 | 58990 |
EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2019-05-08 | 2019-11-19 | 83468 |
EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2022-03-17 | 2022-04-07 | 156836 |
DELATESTRYL | 200MG | SOLUTION | Resolved | 2017-06-16 | 2017-06-24 | 12960 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
Showing 1 to 13 of 13